Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder.

Rothbaum BO, Cahill SP, Foa EB, Davidson JR, Compton J, Connor KM, Astin MC, Hahn CG.

J Trauma Stress. 2006 Oct;19(5):625-38.

PMID:
17075912
2.

Placebo-controlled trial of risperidone augmentation for selective serotonin reuptake inhibitor-resistant civilian posttraumatic stress disorder.

Rothbaum BO, Killeen TK, Davidson JR, Brady KT, Connor KM, Heekin MH.

J Clin Psychiatry. 2008 Apr;69(4):520-5.

PMID:
18278987
3.

Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.

Londborg PD, Hegel MT, Goldstein S, Goldstein D, Himmelhoch JM, Maddock R, Patterson WM, Rausch J, Farfel GM.

J Clin Psychiatry. 2001 May;62(5):325-31.

PMID:
11411812
4.

Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment.

Rapaport MH, Endicott J, Clary CM.

J Clin Psychiatry. 2002 Jan;63(1):59-65.

PMID:
11838628
5.

Exposure therapy and sertraline in social phobia: I-year follow-up of a randomised controlled trial.

Haug TT, Blomhoff S, Hellstrøm K, Holme I, Humble M, Madsbu HP, Wold JE.

Br J Psychiatry. 2003 Apr;182:312-8.

6.

Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapy.

Simon NM, Connor KM, Lang AJ, Rauch S, Krulewicz S, LeBeau RT, Davidson JR, Stein MB, Otto MW, Foa EB, Pollack MH.

J Clin Psychiatry. 2008 Mar;69(3):400-5.

PMID:
18348595
7.

Changes in reported physical health symptoms and social function with prolonged exposure therapy for chronic posttraumatic stress disorder.

Rauch SA, Grunfeld TE, Yadin E, Cahill SP, Hembree E, Foa EB.

Depress Anxiety. 2009;26(8):732-8. doi: 10.1002/da.20518.

8.

Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.

Smajkic A, Weine S, Djuric-Bijedic Z, Boskailo E, Lewis J, Pavkovic I.

J Trauma Stress. 2001 Jul;14(3):445-52.

PMID:
11534876
9.

Treatment of acute stress disorder: a randomized controlled trial.

Bryant RA, Mastrodomenico J, Felmingham KL, Hopwood S, Kenny L, Kandris E, Cahill C, Creamer M.

Arch Gen Psychiatry. 2008 Jun;65(6):659-67. doi: 10.1001/archpsyc.65.6.659.

PMID:
18519824
10.

A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms.

Cohen JA, Mannarino AP, Perel JM, Staron V.

J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):811-9.

PMID:
17581445
11.

Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.

Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K.

Alcohol Clin Exp Res. 2005 Mar;29(3):395-401.

PMID:
15770115
12.
13.
14.

Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.

Robert S, Hamner MB, Ulmer HG, Lorberbaum JP, Durkalski VL.

J Clin Psychiatry. 2006 Oct;67(10):1522-6.

PMID:
17107242
15.

Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo.

Tucker P, Potter-Kimball R, Wyatt DB, Parker DE, Burgin C, Jones DE, Masters BK.

Psychopharmacol Bull. 2003 Summer;37(3):135-49.

PMID:
14608246
16.

A comparison of exposure therapy, stress inoculation training, and their combination for reducing posttraumatic stress disorder in female assault victims.

Foa EB, Dancu CV, Hembree EA, Jaycox LH, Meadows EA, Street GP.

J Consult Clin Psychol. 1999 Apr;67(2):194-200.

PMID:
10224729
17.
18.

Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial.

Hien DA, Levin FR, Ruglass LM, López-Castro T, Papini S, Hu MC, Cohen LR, Herron A.

J Consult Clin Psychol. 2015 Apr;83(2):359-69. doi: 10.1037/a0038719.

19.

Imipramine vs. sertraline in panic disorder: 24-week treatment completers.

Mavissakalian MR.

Ann Clin Psychiatry. 2003 Sep-Dec;15(3-4):171-80.

PMID:
14971862
20.

An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder.

Becker CB, Darius E, Schaumberg K.

Behav Res Ther. 2007 Dec;45(12):2861-73.

PMID:
17612502

Supplemental Content

Support Center